Les coagulations intra-vasculaires disséminées

Cahiers d'Anesthesiologie

Volumn 44, Issue 3, 1996, Pages 219-228

  Amstutz, P ^a   Simo Moyo, J ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b Camp Univ des Sciences Sociales   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; AMINOCAPROIC ACID; ANTITHROMBIN III; APROTININ; HEPARIN; TRANEXAMIC ACID;

BLOOD CLOTTING; BLOOD CLOTTING TEST; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; SEPTIC SHOCK; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; PROGNOSIS;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; DACARBAZINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; SHOCK, SEPTIC;

EID: 0030341549     PISSN: 00079685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Antman K.H. - Microangiopathic hemolytic anemia and cancer. A review. Medicine, 1979, 58, 377.
2. Basu H.K. - Fibrinolysis and abruptio placentae. J. Obst. Gynaecol. Br. Commonw., 1969, 76, 481.
3. Bauer K.A. - Hypercoagulability - A new cofactor in the protein C anticoagulant pathway (ed.). New Engl. J. Med., 1994, 330, 566.
4. Clavarella D., Reed R., Counts R. et al. - Clotting factor levels and the risk of diffuse microvascular bleeding in the massive transfused patient. Br. J. Haematol., 1987, 67, 165.
5. Colman R.W., Robboy S.J., Minna J.D. - Disseminated intravascular coagulation : a reappraisal. Ann. Rev. Med., 1979, 30, 359.
6. |6| Desprez R.M., Horowitz H.I., Hook E.W. - Effects of bacterial endotoxin on rabbit platelets. I. Aggregation and release of platelet factors in vitro. J. Exp. Med., 1961, 114, 857.
7. Dreyfus M., Magny J.F., Bridey F., Schwarz H.P. et al. - Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N. Engl. J. Metd., 1991, 325, 1565.
8. Feinstein D.I. - Diagnosis and management of disseminated intravascular coagulation : the role of heparin therapy. Blood, 1982, 60, 284.
9. Finley B.E. - Acute coagulopathy in pregnancy. Med. Clin. N. Amer., 1989, 73, 723.
10. Fourrier F., Chopin C., Goudemand J. et al. - Septic shock, multiple organ failure and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C and protein S deficiencies. Chest, 1992, 101, 816.
11. Fourrier F., Chopin C., Huart J.J. et al. - Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest, 1993, 104, 882.
12. Furie B., Furie B.C. - Molecular and cellular biology of blood coagulation. New Engl. J. Med., 1992, 326, 800.
13. Gibert C., Amstutz P., Szekely A.M., Pocidalo J.J. - Anomalies de l'hémostase au cours du choc infectieux chez l'homme. Rev. franç. Etud. clin, biol., 1969, 14, 451.
14. Goldfinger D. - Acute hemolytic reactions - a fresh look at pathogenesis and considerations regarding therapy. Transfusion, 1977, 17, 85.
15. Gordon S.G. - Cancer cell procoagulants and their implications. Hematology/Oncology clinics of North America, 1992, 6, 1992.
16. Hack C.E., Ogilvie A.C., Eisele B. et al. - Cl-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intens. Care Med., 1993, 19, S19.
17. Halvorsen S., Skjönsberg D.H., Ruyter R., Godal H.C. - Comparison for detecting soluble fibrin in plasma. An in vitro study. Thromb. Res., 1990, 57, 489.
18. Hardaway R.M. - The role of intravascular clotting in the etiology of shock. Ann. Surg., 1962, 155, 325.
19. Harke H., Rahman S. - Coagulation disorders in massively injured patients. In : Massive transfusion in surgery and trauma. AR RISS Ed. 1 vol., New York, 1982.
20. Harker L.A., Slichter S.J. - Platelet and fibrinogen consumption in man. N. Engl. J. Med., 1972, 257, 999.
21. Hathaway W.E. - Heparin therapy in acute meningococcemia. j. Pediat., 1973, 82, 900.
22. Haynes J., Hyers T., Giclas P. et al. - Elevated fibrin(ogen) degradation products in the adult respiratory distress syndrome. Am. Rev. Resp. Dis., 1980, 122, 841.
23. Horowitz H.I., Des Prez R.M., Hook E.W. - Effects of bacterial endotoxin on rabbit platelets. II. Enhancement of platelet factor 3 activity in vitro and in vivo. J. Exp. Med., 1962, 116, 619.
24. Jørgensen M., Gustafsen K.B., Ernst S., Thostrup Jensen S. - Disseminated intravascular coagulation in critically ill patients - Laboratory diagnosis. Intens. Care World, 1992, 9, 108.
25. Kalter E.S., Daha M.R., Ten Gate J.W. et al. - Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J. Infect. Dis., 1985, 151, 1019.
26. Kaplan M.M. - Acute fatty liver of pregnancy. N. Engl. J. Med., 1985,313, 367.
27. Kemkes-Matthes B., Lasch H.G. Alterations of coagulation inhibitors in consumption coagulopathy. In : DIC : Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular fibrin Formation. G. Müller-Berghaus et al., Ed. p. 159 Eisevier Science Publishers B.V., Amsterdam, 1993.
28. Lian E.C.Y. - Thrombotic thrombocytopenic purpura. Ann. Rev. Med., 1988, 39, 203.
29. Malik A., Morgan M. - Mechanism of thrombin-induced lung vascular injury and edema. Am. Rev. Resp. Dis., 1987, 138, 467.
30. Mammen E.F. - Coagulation abnormalities in liver disease. Hematology/ Oncology Clinics of North America, 1992, 6, 1247.
31. Mant M.J., King E.G. - Severe, acute disseminated intravascular coagulation. Am. J. Med., 1979, 67, 557.
32. Manwaring D., Thorning D., Curreri P.W. - Mechanisms of acute pulmonary dysfunction induced by fibrinogen product D. Surgery, 1978, 84, 45.
33. Marlar R.A., Endres-Brooks J., Miller C. - Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood, 1985, 66, 59.
34. [34[ Morrison D.C., Cochrane G.G. - Direct evidence for Hageman factor (factor XII) activation by lipopolysaccharides (endotoxins). J. Exp. Med., 1974, 140, 797.
35. Nuijens J.H., Huijbregts C.C., Eerenberg-Belmer A.J. et al. - Quantification of plasma factor Xlla-Cl(-) inhibitor and kallicrein-Cl(-) inhibitor complexes in sepsis. Blood, 1988, 72, 1841.
36. Østerud B. - Leucocytes, adhesive proteins and disseminated intravascular coagulation : treatment of DIG with plasma/leukapheresis ? In : DIG : Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular fibrin Formation. G. Müller-Berghaus et al, Ed., p. 33. Elsevier Science Publishers B.V., Amsterdam, 1993.
37. Pixley R.A., De La Cadena R., Page J.D. et al. - The contact system contributes to hypotension but not to disseminated intravascular coagulation in lethal bacteremia : in vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J. Clin. Invest., 1993, 91, 61.
38. Pizzo S.V. - Serpin receptor I : A hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes. Am. J. Med., 1989, 87, 3BI1S.
39. Risberg B., Webb W.R., Osburn K. et al. - Pulmonary microvascular leakage after microembolization and hemodilution. Surgery, 1982, 92, 409.
40. Rodeghiero F., Avvisafi G., Castaman G. et al. - Early deaths and anti-hemorrhagic treatment in acute promyelocytic leukemia : a GIMEMA retrospective study in 268 consecutive patients. Blood, 1990, 75, 2112.
41. Rosen P.J. - Bleeding problems in the cancer patient. Hematology/Oncology Clinks of North America, 1992, 6, 1315.
42. Sala N., Fontcuberta J., Rutilant L.L. - New biological concepts on coagulation inhibitors. Intens. Care Med., 1993, 19, S3.
43. Seifried E., Lampl L., Seidl C. et al. - Alterations of coagulation and fibrinolysis during the preclinical phase after polytrauma. In : DIG : Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular fibrin Formation. Müller-Berghaus et al., Ed., p. 147. Elsevier Science Publishers B.V., Amsterdam, 1993.
44. Sher G., Statland B.E. - Abruptio placentae with coagulopathy : a rational basis for management. Clin. Obst. Gynecol., 1985, 28, 15.
45. Song K.S. Kim B.S., Lee S.Y. - Diagnostic efficacy of D-Dimer assay in evaluating disseminated intravascular coagulation. Thromb. Haem., 1991, 65, 1235.
46. Spero J.A., Lewis J.H., Hasiba U. Disseminated intravascular coagulation. Thromb. Haem., 1980, 43, 28.
47. Spicer T.E., Rau J.M. - Purpura fulminans. Am. J. Med, 1976, 61, 566.
48. (48] Spielvogel A.R. - An ultrastructural study of the mechanisms of platelet-endotoxin interaction. J. Exp. Med., 1967, 726, 235.
49. Suffredini A.F., Harpel P.C., Parrillo J.E. - Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N. Engl. J. Med., 1989, 320, 1165.
50. Sun N.C.J., Bowie E.J.W., Kazmier F.J. et al. - Blood coagulation studies in patients with cancer. Mayo Clin. Proc., 1974, 49, 636.
51. Szekely A.M., Amstutz P. - Coagulation intravasculaire et choc toxi-infectieux. A propos de 30 observations. Arch. Anal. Pathol., 1968, 16, 313.
52. Tallman M.S., Waan H.C. - Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood, 1992, 79, 543.
53. Taylor F.B. - Role of tissue factor in the coagulant and inflammatory response to LD1OO E. coli sepsis and in the early diagnosis of DIC in the baboon. In : DIC : Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular fibrin Formation. G. Müller-Berghaus et al., Ed., p. 19. Eisevier Science Publishers B.V., Amsterdam, 1993.
54. Van Dam P., Renier M., Baekelandt M. - Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes and low platelets in severe preeclampsia. Obstet. Gynecol., 1989, 73, 97.
55. Van der Poll T., Bueller H.R., Ten Cate H. et al. - Activation of coagulation after administration of tumor ne-crosis factor to normal subjects. N. Engl. J. Med., 1990, 322, 1622.
56. er Congrès international de Néphrologie, Genève-Evian, 1960, l vol., Karger Pub, Basel, 1961.
57. Vinazzer H. - Therapeutic use of Antithrombin III in shock and disseminated intra-vascular coagulation. Semin. Thromb. Hemost., 1989, 15, 347.
58. Warrell Jr R.P., Frankel S.R., Miller W.H. et al. - Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med., 1991,324, 1385.
59. Williams E.C. - Plasma alpha2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders. Arch. Intern. Med., 1989, 149, 1769.